Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics

被引:83
作者
Ensign, Wayne
Hill, Nicole
Heward, Christopher B.
机构
[1] Kronos Sci Labs Inc, Phoenix, AZ 85016 USA
[2] USN, Hlth Res Ctr, San Diego, CA 92152 USA
关键词
D O I
10.1373/clinchem.2005.059949
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Background: Our study seeks to clarify the extent of differences in analytical results, from a clinical perspective, among 4 leading technologies currently used in clinical reference laboratories for the analysis of LDL subfractions: gradient gel electrophoresis (GGE), ultra-centrifugation-vertical auto profile (VAP), nuclear magnetic resonance (NMR), and tube gel electrophoresis (TGE). Methods: We collected 4 simultaneous blood samples from 40 persons (30 males and 10 females) to determine LDL subclasses in 4 different clinical reference laboratories using different methods for analysis. LDL subfractions were assessed according to LDL particle size and the results categorized according to LDL phenotype. We compared results obtained from the different technologies. Results: We observed substantial heterogeneity of results and interpretations among the 4 methods. Complete agreement among methods with respect to LDL subclass phenotyping occurred in only 8% (n = 3) of the persons studied. NMR and GGE agreed most frequently at 70% (n = 28), whereas VAP matched least often. Conclusions: As measurement of LDL subclasses becomes increasingly important, standardization of methods is needed. Variation among currently available methods renders them unreliable and limits their clinical usefulness. (c) 2006 American Association for Clinical Chemistry
引用
收藏
页码:1722 / 1727
页数:6
相关论文
共 33 条
[1]
[Anonymous], 1992, Current Opinion in Lipidology
[2]
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[3]
ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[4]
Austin Melissa A., 1994, Current Opinion in Lipidology, V5, P395, DOI 10.1097/00041433-199412000-00002
[5]
ROLE OF LOW-DENSITY LIPOPROTEIN RECEPTOR IN REGULATING CONTENT OF FREE AND ESTERIFIED CHOLESTEROL IN HUMAN FIBROBLASTS [J].
BROWN, MS ;
FAUST, JR ;
GOLDSTEIN, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (04) :783-793
[6]
LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE AND CORONARY-ARTERY DISEASE [J].
CAMPOS, H ;
GENEST, JJ ;
BLIJLEVENS, E ;
MCNAMARA, JR ;
JENNER, JL ;
ORDOVAS, JM ;
WILSON, PWF ;
SCHAEFER, EJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (02) :187-195
[7]
EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) :4-12
[8]
CHUNG BH, 1986, METHOD ENZYMOL, V128, P181
[9]
REEVALUATION OF SERUM-PLASMA DIFFERENCES IN TOTAL CHOLESTEROL CONCENTRATION [J].
CLOEY, T ;
BACHORIK, PS ;
BECKER, D ;
FINNEY, C ;
LOWRY, D ;
SIGMUND, W .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (20) :2788-2789
[10]
COOPER GR, 1988, CLIN CHEM, V34, P95